Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,383.30 +28.92 0.19%
S&P 500 1,670.54 +3.07 0.18%
Nasdaq 3,508.93 +9.96 0.28%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

MIV Therapeutics Inc

+ Add to Watchlist

MIVI:US

0.0200 USD 0.00000.00%

As of 20:10:00 ET on 05/17/2013.

Company Profile for MIV Therapeutics Inc (MIVI)

MIV Therapeutics Inc., through its subsidiary MIVI Technologies, is a bio-medical development company. The Company has developed a laser cut coronary stent, which is being further designed and engineered to be integrated with its biocompatible coating.

Contact Information

MIV Therapeutics Inc

Unit 1 8765 Ash Street
Vancouver, BC V6P 6T3
Canada
Phone: 1-604-301-9545
Fax: 1-604-301-9546

Key Executives for MIV Therapeutics Inc (MIVI)

Chris ChenCEO/CFO/Pres/Secy/Treasurer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil